TherapeuticsMD, Inc. (TXMD) has seen some recent volatility in the marketplace and its shares were last quoted at $2.0500 yesterday. Investors are starting to take notice of TXMD as the shares traded as high as $2.0800 and as low as $1.8100 in the last market trading session.
TherapeuticsMD, Inc. (TXMD) average trading volume is 5.23M. However, in the last market trading session TherapeuticsMD, Inc. (TXMD) exchanged 5,973,485 shares. The First support level on TXMD is $1.89 and the First resistance level on TXMD is $2.53. TXMD 50-day moving average is $1.6023 and TXMD 200day moving average is $1.5352.
TherapeuticsMD, Inc. (TXMD) most recent performance has been shown by the recent movement in TXMD shares. TXMD has performed 33.99% over the past 4 weeks, TXMD has performed 60.16% over the past 3 months and TXMD has shown 9.63% over the past 12 months. TherapeuticsMD, Inc. (TXMD) has a 12 month range of $0.8500 to $4.3200. TherapeuticsMD, Inc. (TXMD) is trading 140.33% from its 12 month low and -52.55% from its 12 month high. TherapeuticsMD, Inc. (TXMD) is displaying a 35.01% short float displaying the quantity short in the float.
TXMD has 271.46M shares outstanding and 236.97M shares in the float. TherapeuticsMD, Inc. (TXMD) at this time has a market cap of $587.08M and income of -193.50M. The EPS next quarter for TXMD is -0.17 and forecasted EPS next year is 51.60%. The market cap of TherapeuticsMD, Inc. (TXMD) at $587.08M signifies how many Investors own shares of TXMD and is based off the last price ($2.0500) of TXMD and the quantity of shares outstanding (271.46M) with TherapeuticsMD, Inc. (TXMD).
TherapeuticsMD, Inc. (TXMD) has total cash (mrq) of 170.1M, total cash per share (mrq) of 0.63, total debt of TXMD stands at 253.96M. TherapeuticsMD, Inc. (TXMD) operating cash flow (ttm) is -166.65M, TXMD leveraged free cash flow (ttm) is -121.91M.
TXMD is trading 13.34% above (bullish) its SMA20, 38.64% above (bullish) its SMA50 and 9.61% above (bullish) its SMA200.